AAAAAA
Results:
1-22
|
Results: 22
Authors:
Recasens, M
Aguilera, E
Ampurdanes, S
Tapias, JMS
Simo, O
Casamitjana, R
Conget, I
Citation: M. Recasens et al., Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C, DIABET MED, 18(9), 2001, pp. 764-767
Authors:
Martinez, E
Mocroft, A
Garcia-Viejo, MA
Perez-Cuevas, JB
Blanco, JL
Mallolas, J
Bianchi, L
Conget, I
Blanch, J
Phillips, A
Gatell, JM
Citation: E. Martinez et al., Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study, LANCET, 357(9256), 2001, pp. 592-598
Authors:
Conget, I
Costa, A
Casamitjana, R
Citation: I. Conget et al., Insulin sensitivity, insulin secretion and glucose tolerance in a group ofsubjects at risk for type 2 diabetes mellitus: some methodological issues, MED CLIN, 117(9), 2001, pp. 357-358
Authors:
Conget, I
Real, JMF
Costa, A
Casamitjana, R
Ricart, W
Citation: I. Conget et al., Insulin secretion and insulin sensitivity in relation to glucose tolerancein a group of subjects at a high risk for type 2 diabetes mellitus, MED CLIN, 116(13), 2001, pp. 491-492
Authors:
Panerai, AE
Nicoletti, F
Sacedote, P
Arvidsson, L
Conget, I
Gomis, R
Bartorelli, A
Sandler, S
Citation: Ae. Panerai et al., MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice, DIABETOLOG, 44(7), 2001, pp. 839-847
Authors:
Nicoletti, F
Conget, I
Di Marco, R
Speciale, AM
Moringo, R
Bendtzen, K
Gomis, R
Citation: F. Nicoletti et al., Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes, DIABETOLOG, 44(3), 2001, pp. 309-311
Authors:
Martinez, E
Garcia-Viejo, MA
Blanco, JL
Bianchi, L
Buira, E
Conget, I
Casamitjana, R
Mallolas, J
Gatell, JM
Citation: E. Martinez et al., Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy, CLIN INF D, 31(5), 2000, pp. 1266-1273
Authors:
Nicoletti, F
Di Marco, R
Conget, I
Gomis, R
Edwards, C
Papaccio, G
Bendtzen, K
Sandler, S
Citation: F. Nicoletti et al., Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin, J AUTOIMMUN, 15(4), 2000, pp. 395-405
Authors:
Costa, A
Bescos, M
Velho, G
Chevre, JC
Vidal, J
Sesmilo, G
Bellanne-Chantelot, C
Froguel, P
Casamitjana, R
Rivera-Fillat, F
Gomis, R
Conget, I
Citation: A. Costa et al., Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families, EUR J ENDOC, 142(4), 2000, pp. 380-386
Authors:
Costa, A
Carmona, F
Martinez-Roman, S
Quinto, L
Levy, I
Conget, I
Citation: A. Costa et al., Post-partum reclassification of glucose tolerance in women previously diagnosed with gestational diabetes mellitus, DIABET MED, 17(8), 2000, pp. 595-598
Authors:
Costa, A
Rodriguez, C
Gomis, R
Conget, I
Casamitjana, R
Bescos, M
Citation: A. Costa et al., Follow up of a HNF-1 alpha mutant carrier with a severely impaired beta cell function, DIABET RE C, 48(1), 2000, pp. 67-70
Authors:
Costa, A
Conget, I
Casamitjana, R
Citation: A. Costa et al., Consensus Development Conference on Diabetic Foot Wound Care - Capillary whole-blood measurement of islet autoantibodies - Response, DIABET CARE, 23(6), 2000, pp. 874-874
Authors:
Vidal, J
Fernandez-Balsells, M
Sesmilo, G
Aguilera, E
Casamitjana, R
Gomis, R
Conget, I
Citation: J. Vidal et al., Effects of nicotinamide and intravenous insulin therapy in newly diagnosedtype 1 diabetes, DIABET CARE, 23(3), 2000, pp. 360-364
Authors:
Aguilera, E
Morinigo, R
Recasens, M
Casamitjana, R
Conget, I
Citation: E. Aguilera et al., Glycemic control and impaired autonomic function - Is glucose the sole culprit? Response to Decochex et al. - Autoantibody levels during the early course of type 1 diabetes, DIABET CARE, 23(12), 2000, pp. 1864-1865
Authors:
Costa, A
Rios, M
Fernandez, M
Gomis, R
Conget, I
Citation: A. Costa et al., The 1997 ADA diabetes diagnostic categories: impact on employees' annual medical examination, DIABET MED, 16(6), 1999, pp. 528-529
Authors:
Rodriguez-Villar, C
Conget, I
Casamitjana, R
Ercilla, G
Gomis, R
Citation: C. Rodriguez-villar et al., Effects of insulin administration in a group of high-risk, non-diabetic, first-degree relatives of Type 1 diabetic patients: an open pilot trial, DIABET MED, 16(2), 1999, pp. 160-163
Authors:
Costa, A
Conget, I
Citation: A. Costa et I. Conget, Fasting plasma glucose diagnostic criteria for diabetes mellitus. Reply, DIABET MED, 16(11), 1999, pp. 970-970
Authors:
Martinez, E
Conget, I
Lozano, L
Casamitjana, R
Gatell, JM
Citation: E. Martinez et al., Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine, AIDS, 13(7), 1999, pp. 805-810
Authors:
Costa, A
Conget, I
Treserras, R
Gomis, R
Citation: A. Costa et al., Basal glycemia and glycated hemoglobin, their role in the detection of abnormal glucose tolerance in relatives of patients with type 2 diabetes, MED CLIN, 112(7), 1999, pp. 241-244
Authors:
Zaccone, P
Phillips, J
Conget, I
Gomis, R
Haskins, K
Minty, A
Bendtzen, K
Cooke, A
Nicoletti, F
Citation: P. Zaccone et al., Interleukin-13 prevents autoimmune diabetes in NOD mice, DIABETES, 48(8), 1999, pp. 1522-1528
Authors:
Nicoletti, F
Zaccone, P
Conget, I
Gomis, R
Moller, C
Meroni, P
Bendtzen, K
Trepicchio, W
Sandler, S
Citation: F. Nicoletti et al., Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice, DIABETES, 48(12), 1999, pp. 2333-2339
Authors:
Jansson, PA
Ebeling, P
Smith, U
Conget, I
Coves, VJ
Gomis, R
Lalli, C
Del Sindaco, P
Bolli, GB
Koivisto, VA
Citation: Pa. Jansson et al., Improved glycemic control can be better maintained with insulin lispro than with human regular insulin, DIABET NUTR, 11(3), 1998, pp. 194-199
Risultati:
1-22
|